Trial Profile
An Open-label Pilot Study Evaluating Synera in the Treatment of Patients With Patellar Tendinopathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2013
Price :
$35
*
At a glance
- Drugs Lidocaine/tetracaine (Primary)
- Indications Musculoskeletal pain; Tendon injuries
- Focus Therapeutic Use
- 30 May 2013 Pooled analysis presented at the 60th Annual Meeting of the American College of Sports Medicine, according to a Nuvo Research media release.
- 10 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.